Skip to content

Restorelle Direct Fix Anterior and Posterior (A&P) for Female Pelvic Organ Prolapse: A Prospective Post Market Study

Restorelle Direct Fix A&P for Female Pelvic Organ Prolapse: A Prospective Post Market Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01378065
Acronym
(A&P)
Enrollment
31
Registered
2011-06-22
Start date
2011-06-30
Completion date
2013-09-30
Last updated
2020-05-12

For informational purposes only โ€” not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse (POP)

Keywords

POP, pelvic organ prolapse, anterior prolapse, posterior prolapse, vaginal prolapse, vaginal floor reconstruction

Brief summary

This is a prospective, multi-center study designed to assess the palpability of the Restorelle Direct Fix A&P mesh after vaginal reconstruction surgery.

Interventions

DEVICERestorelle Direct Fix A&P

Restorelle Direct Fix A&P is a permanently implantable synthetic mesh for reconstruction of the pelvic floor secondary to the prolapse or protrusion of the pelvic organs into or out of the vaginal canal.

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult female at least 18 years of age * Willing and able to provide written informed consent * Diagnosed with clinically significant pelvic organ prolapse of Stage 2 or higher as determined by Pelvic Organ Prolapse Quantification System (POP-Q) requiring surgical intervention in the anterior and/or posterior compartment * Willing and able to complete all follow-up visits and procedures indicated in the protocol

Exclusion criteria

* Concurrent surgical treatment of pelvic organ prolapse using anything other than the Restorelle Direct Fix A&P * Confirmed Stage 2 or higher prolapse as determined by POP-Q for a compartment that is not being repaired in the same procedure * Previous pelvic organ prolapse repair using synthetic grafts * Patients requiring a total hysterectomy (i.e. removal of the cervix) at the time of vaginal reconstruction * Patients requiring a procedure for fecal incontinence (i.e.) anal sphincteroplasty) at the time of vaginal reconstruction * Pregnant or a desire to become pregnant * Previous radiation or other treatments for cancer in the pelvic area * Immunosuppression and/or current systemic steroid user * On any anticoagulation therapy at the time of implant or with bleeding diathesis

Design outcomes

Primary

MeasureTime frameDescription
Palpability of the Restorelle Direct Fix Anterior and Posterior (A&P)BaselineMeasured via palpability scale with possible outcomes of none, mild, moderate, or severe.
Palpability of the Restorelle Direct Fix A&P6 weeksMeasured via palpability scale with possible outcomes of none, mild, moderate, or severe.

Secondary

MeasureTime frameDescription
Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 6 Weeks6 weeksSurgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 6 weeks. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 3 Months3 monthsPercentage of participants with surgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 3 months. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 6 Months6 monthsPercentage of participants with surgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 6 months. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 12 Months12 monthsPercentage of participants with surgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 12 months. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Patient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.12 monthsThe PGI-I Index consists on one question and was collected at 12 months. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.
Percentage of Participants With Mesh Exposure/Extrusion After Vaginal Reconstruction Surgery at 12 Months.12 monthsPercentage of participants with anterior and posterior compartment mesh exposure/extrusion after vaginal reconstruction with Restorelle Direct Fix at 12 months. Per the protocol, mesh extrusion is defined as passage gradually out of a body structure or tissue. Mesh exposure is defined as a condition of displaying, revealing, exhibiting or making accessible e.g. vaginal mesh visualized through separated vaginal epithelium.
Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 6 Week Visit6 weekPercentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 6 week visit. Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 3 Month Visit3 monthPercentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 3 month visit. Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 6 Month Visit6 monthPercentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 6 month visit Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the12 Month Visit12 monthPercentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 12 month visit. Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).
Patient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.6 weeksThe PGI-I Index consists on one question and was collected at 6 weeks. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.
Patient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.3 monthsThe PGI-I Index consists on one question and was collected at 3 months. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.
Rates of de Novo Dyspareunia6 weeksPercentage of de novo dyspareunia measured via validated Participant Sexual Function Questionnaire-12 (PISQ-12) questionnaire at 6 weeks. The specific PISQ-12 score was based upon Question 3.5, Do you feel pain during sexual intercourse? The subjects' response was counted as having de novo dyspareunia if the response was sometimes usually or always.
Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 3 MonthsBaseline and 3 monthsBladder function is measured by UDI-6 Questionnaire at 3 months. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.
Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 MonthsBaseline and 6 monthsBladder function is measured by UDI-6 Questionnaire at 6 months. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.
Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 12 MonthsBaseline and 12 monthsBladder function is measured by UDI-6 Questionnaire at 12 months. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.
Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 WeeksBaseline and 6 weeksSexual function in women with pelvic organ prolapse is measured by the PISQ-12 at 6 weeks. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.
Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 3 MonthsBaseline and 3 monthsSexual function in women with pelvic organ prolapse is measured by the PISQ-12 at 3 months. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.
Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 MonthsBaseline and 6 monthsSexual function in women with pelvic organ prolapse is measured by the PISQ-12 at 6 months. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.
Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 12 MonthsBaseline and 12 monthsSexual function in women with pelvic organ prolapse is measured by the PISQ-12 at12 months. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.
Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Week VisitBaseline and 6 weeksColorectal-anal Distress Inventory is measured by the CRADI-8 at 6 weeks. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).
Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 3 Month VisitBaseline and 3 monthsColorectal-anal Distress Inventory is measured by the CRADI-8 at 3 months. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).
Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Month VisitBaseline and 6 monthsColorectal-anal Distress Inventory is measured by the CRADI-8 at 6 months. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).
Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the12 Month VisitBaseline and 12 monthsColorectal-anal Distress Inventory is measured by the CRADI-8 at 12 months. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).
Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 WeeksBaseline and 6 weeksBladder function is measured by UDI-6 Questionnaire at 6 weeks. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.
Patient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.6 monthsThe PGI-I Index consists on one question and was collected at 6 months. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.

Countries

United States

Participant flow

Participants by arm

ArmCount
Restorelle Direct Fix
Subjects with clinically significant pelvic organ prolapse of Stage 2 or higher with surgical intervention using Restorelle Direct Fix A & P in the anterior and/or posterior compartment.
30
Total30

Baseline characteristics

CharacteristicRestorelle Direct Fix
Age, Continuous62.1 years
STANDARD_DEVIATION 12.8
Body Mass Index (BMI)27.9 Kg/m^2
STANDARD_DEVIATION 5.6
Height64.3 Inches
STANDARD_DEVIATION 2.9
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
30 Participants
Sex: Female, Male
Male
0 Participants
Weight164.7 pound
STANDARD_DEVIATION 36.8

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
โ€” / โ€”
other
Total, other adverse events
3 / 30
serious
Total, serious adverse events
2 / 30

Outcome results

Primary

Palpability of the Restorelle Direct Fix Anterior and Posterior (A&P)

Measured via palpability scale with possible outcomes of none, mild, moderate, or severe.

Time frame: Baseline

Population: All subjects

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - apex: Mild0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - apex: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - apex: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - inside hymenal ring: None30 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - inside hymenal ring: Mild0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - apex: None29 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - inside hymenal ring: None30 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - inside hymenal ring: Mild0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - 4 cm from introitus at midline: None30 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - 4 cm from introitus at midline: Mild0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - 4 cm from introitus at midline: Moderat0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - 4 cm from introitus at midline: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Anterior - apex: None30 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - 4 cm from introitus at midline: None29 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - 4 cm from introitus at midline: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - 4 cm from introitus at midline: Modera0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - 4 cm from introitus at midline:Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - apex: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - apex: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix Anterior and Posterior (A&P)Posterior - apex: Severe0 participants
Primary

Palpability of the Restorelle Direct Fix A&P

Measured via palpability scale with possible outcomes of none, mild, moderate, or severe.

Time frame: 6 weeks

Population: All subjects

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: None29 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: None27 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Mild3 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Moderat0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: None26 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Mild4 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: None30 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Mild0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: None27 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Mild2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Modera1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline:Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: None27 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Mild2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Moderate1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Severe0 participants
Primary

Palpability of the Restorelle Direct Fix A&P

Measured via palpability scale with possible outcomes of none, mild, moderate, or severe.

Time frame: 12 months

Population: All subjects

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: None29 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: None26 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Mild3 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Moderat1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: None26 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Mild4 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: None29 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: None28 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Mild2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Modera0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline:Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: None27 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Mild3 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Severe0 participants
Primary

Palpability of the Restorelle Direct Fix A&P

Measured via palpability scale with possible outcomes of none, mild, moderate, or severe.

Time frame: 6 months

Population: All subjects

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: None30 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Mild0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: None25 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Mild4 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Moderat1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: None25 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Mild2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Moderate3 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: None28 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Moderate1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: None26 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Mild3 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Modera1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline:Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: None27 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Moderate2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Severe0 participants
Primary

Palpability of the Restorelle Direct Fix A&P

Measured via palpability scale with possible outcomes of none, mild, moderate, or severe.

Time frame: 3 months

Population: All study subjects

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Mild1 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: None26 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Mild4 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Moderat0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Mild2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - inside hymenal ring: None29 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - 4 cm from introitus at midline: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: None26 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Mild4 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PAnterior - apex: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: None28 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - inside hymenal ring: Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: None28 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Mild2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline: Modera0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - 4 cm from introitus at midline:Severe0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: None28 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Mild2 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Moderate0 participants
Restorelle Direct FixPalpability of the Restorelle Direct Fix A&PPosterior - apex: Severe0 participants
Secondary

Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 12 Months

Bladder function is measured by UDI-6 Questionnaire at 12 months. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.

Time frame: Baseline and 12 months

Population: All subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 12 MonthsBaseline45.1 units on a scaleStandard Deviation 27.2
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 12 Months12 months18.1 units on a scaleStandard Deviation 21.3
p-value: <0.001t-test, 2 sided
Secondary

Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 3 Months

Bladder function is measured by UDI-6 Questionnaire at 3 months. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.

Time frame: Baseline and 3 months

Population: All subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 3 MonthsBaseline45.1 units on a scaleStandard Deviation 27.2
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 3 Months3 months17.1 units on a scaleStandard Deviation 17.3
p-value: <0.001t-test, 2 sided
Secondary

Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 Months

Bladder function is measured by UDI-6 Questionnaire at 6 months. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.

Time frame: Baseline and 6 months

Population: All subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 MonthsBaseline45.1 units on a scaleStandard Deviation 27.2
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 Months6 months16.4 units on a scaleStandard Deviation 18.7
p-value: <0.001t-test, 2 sided
Secondary

Bladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 Weeks

Bladder function is measured by UDI-6 Questionnaire at 6 weeks. The UDI-6 measures bladder function. The range of responses is: 1-4 with (1) not at all, (2) somewhat, (3) moderately, and (4 quite a bit). To allow for missing responses, the average score of items responded to, rather than the total, is taken. The average, which ranges from 1 to 4, is multiplied by 25 to put scores on a scale of 0 to 100. Higher scores indicate worse symptoms.

Time frame: Baseline and 6 weeks

Population: All subjects.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 WeeksBaseline45.1 units on a scaleStandard Deviation 27.2
Restorelle Direct FixBladder Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Urinary Distress Inventory-6 (UDI-6) Questionnaire at 6 Weeks6 weeks25.7 units on a scaleStandard Deviation 19
p-value: <0.001t-test, 2 sided
Secondary

Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the12 Month Visit

Colorectal-anal Distress Inventory is measured by the CRADI-8 at 12 months. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).

Time frame: Baseline and 12 months

Population: All subjects

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the12 Month VisitBaseline24.9 units on a scaleStandard Deviation 20.7
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the12 Month Visit12 months10.8 units on a scaleStandard Deviation 14
Comparison: Analysis baseline to 12 months.p-value: <0.001t-test, 2 sided
Secondary

Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 3 Month Visit

Colorectal-anal Distress Inventory is measured by the CRADI-8 at 3 months. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).

Time frame: Baseline and 3 months

Population: All subjects

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 3 Month VisitBaseline24.9 units on a scaleStandard Deviation 20.7
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 3 Month Visit3 months15.3 units on a scaleStandard Deviation 16.7
Comparison: Analysis baseline to 3 months.p-value: 0.004t-test, 2 sided
Secondary

Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Month Visit

Colorectal-anal Distress Inventory is measured by the CRADI-8 at 6 months. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).

Time frame: Baseline and 6 months

Population: All subjects

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Month VisitBaseline24.9 units on a scaleStandard Deviation 20.7
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Month Visit6 months14.1 units on a scaleStandard Deviation 16.1
Comparison: Analysis baseline to 6 months.p-value: <0.001t-test, 2 sided
Secondary

Bowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Week Visit

Colorectal-anal Distress Inventory is measured by the CRADI-8 at 6 weeks. The range of responses is 1-4 with (1) Not at all, (2) Somewhat, (3) Moderately, and (4), Quite a bit. Scores are calculated by multiplying the mean value of all questions answered by 25. The range of responses is: 0-100 with 0 (least distress) to 100 (most distress).

Time frame: Baseline and 6 weeks

Population: All subjects

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Week VisitBaseline24.9 units on a scaleStandard Deviation 20.7
Restorelle Direct FixBowel Function After Vaginal Reconstruction Surgery With Restorelle Direct Fix A & P Measured by Colorectal-Anal Distress Inventory 8 (CRADI-8) Questionnaire at the 6 Week Visit6 weeks15.7 units on a scaleStandard Deviation 15.7
Comparison: Analysis baseline to 6 weeks.p-value: 0.001t-test, 2 sided
Secondary

Patient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.

The PGI-I Index consists on one question and was collected at 12 months. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.

Time frame: 12 months

Population: All subjects

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.Very much better18 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.Much better4 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.A little better4 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.No change3 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.A little worse1 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.Much worse0 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 12 Months.Very much worse0 participants
Secondary

Patient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.

The PGI-I Index consists on one question and was collected at 3 months. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.

Time frame: 3 months

Population: The 29 subjects who completed the PGI-I at the three month follow up visit.

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.Very much better14 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.Much better9 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.A little better2 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.No change3 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.A little worse1 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.Much worse0 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 3 Months.Very much worse0 participants
Secondary

Patient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.

The PGI-I Index consists on one question and was collected at 6 months. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.

Time frame: 6 months

Population: The 29 subjects who completed the PGI-I at the six month follow up visit.

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.Much worse1 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.Very much better12 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.Much better7 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.A little better6 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.No change2 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.A little worse1 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Index Since Treatment at 6 Months.Very much worse0 participants
Secondary

Patient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.

The PGI-I Index consists on one question and was collected at 6 weeks. The question is Check the box that best describes how your condition is now, compared with how it was before you had the operation. There are seven possible responses including very much better, much better, a little better, no change, a little worse, much worse and very much worse and the subject chooses one response.

Time frame: 6 weeks

Population: The 29 subjects who completed the PGI-I at the six week follow up visit.

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.Very much better15 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.Much better10 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.A little better1 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.No change1 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.A little worse0 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.Much worse2 participants
Restorelle Direct FixPatient Global Impression of Improvement (PGI-I) Questionnaire Since Treatment at 6 Weeks.Very much worse0 participants
Secondary

Percentage of Participants With Mesh Exposure/Extrusion After Vaginal Reconstruction Surgery at 12 Months.

Percentage of participants with anterior and posterior compartment mesh exposure/extrusion after vaginal reconstruction with Restorelle Direct Fix at 12 months. Per the protocol, mesh extrusion is defined as passage gradually out of a body structure or tissue. Mesh exposure is defined as a condition of displaying, revealing, exhibiting or making accessible e.g. vaginal mesh visualized through separated vaginal epithelium.

Time frame: 12 months

Population: All study subjects.

ArmMeasureGroupValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Mesh Exposure/Extrusion After Vaginal Reconstruction Surgery at 12 Months.Rate of mesh exposure3.3 percentage of subjects
Restorelle Direct FixPercentage of Participants With Mesh Exposure/Extrusion After Vaginal Reconstruction Surgery at 12 Months.Rate of mesh extrusion0.0 percentage of subjects
Secondary

Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the12 Month Visit

Percentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 12 month visit. Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 12 month

Population: The 6 subjects who were treated in the posterior compartment with Restorelle Direct Fix.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the12 Month Visit100 percentage of subjects
Secondary

Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 3 Month Visit

Percentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 3 month visit. Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 3 month

Population: The six subjects who had posterior compartment vaginal reconstruction surgery.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 3 Month Visit100 percentage of subjects
Secondary

Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 6 Month Visit

Percentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 6 month visit Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 6 month

Population: The 5 subjects who were treated in the posterior compartment with Restorelle Direct Fix and have POP-Q measurement recorded at the six month follow-up visit.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 6 Month Visit100 percentage of subjects
Secondary

Percentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 6 Week Visit

Percentage of participants with surgical success of the posterior compartment after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at the 6 week visit. Surgical success is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 6 week

Population: The 6 subjects who were treated in the posterior compartment with Restorelle Direct Fix.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success of the Posterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at the 6 Week Visit100 percentage of subjects
Secondary

Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 12 Months

Percentage of participants with surgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 12 months. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 12 months

Population: The 27 subjects who were treated with Restorelle Direct Fix in the anterior compartment.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 12 Months100 percentage of subjects
Secondary

Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 3 Months

Percentage of participants with surgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 3 months. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 3 months

Population: The 27 subjects who were treated with Restorelle Direct Fix in the anterior compartment.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 3 Months100 percentage of subjects
Secondary

Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 6 Months

Percentage of participants with surgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 6 months. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 6 months

Population: The 27 subjects who were treated with Restorelle Direct Fix in the anterior compartment.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 6 Months96.3 percentage of subjects
Secondary

Percentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 6 Weeks

Surgical success rates of the anterior compartments after vaginal reconstruction surgery via Pelvic Organ Prolapse Quantification system (POP-Q) at 6 weeks. Surgical success rate is defined as the post-operative point of maximal prolapse being less than 0 cm (i.e. above the hymenal ring).

Time frame: 6 weeks

Population: The 27 subjects who were treated with Restorelle Direct Fix in the anterior compartment.

ArmMeasureValue (NUMBER)
Restorelle Direct FixPercentage of Participants With Surgical Success Rates of the Anterior Compartment After Vaginal Reconstruction Surgery Via Pelvic Organ Prolapse Quantification System (POP-Q) at 6 Weeks100 percentage of subjects
Secondary

Rates of de Novo Dyspareunia

Percentage of de novo dyspareunia measured via validated Participant Sexual Function Questionnaire-12 (PISQ-12) questionnaire at 6 weeks. The specific PISQ-12 score was based upon Question 3.5, Do you feel pain during sexual intercourse? The subjects' response was counted as having de novo dyspareunia if the response was sometimes usually or always.

Time frame: 6 weeks

Population: The 12 sexually active subjects without dyspareunia at baseline.

ArmMeasureValue (NUMBER)
Restorelle Direct FixRates of de Novo Dyspareunia8.3 percentage of subjects
Secondary

Rates of de Novo Dyspareunia

Percentage of de novo dyspareunia measured via validated Participant Sexual Function Questionnaire-12 (PISQ-12) questionnaire at 3 months. The specific PISQ-12 score was based upon Question 3.5, Do you feel pain during sexual intercourse? The subjects' response was counted as having de novo dyspareunia if the response was sometimes usually or always.

Time frame: 3 months

Population: The 12 sexually active subjects without dyspareunia at baseline.

ArmMeasureValue (NUMBER)
Restorelle Direct FixRates of de Novo Dyspareunia8.3 percentage of subjects
Secondary

Rates of de Novo Dyspareunia

Percentage of de novo dyspareunia measured via validated Participant Sexual Function Questionnaire-12 (PISQ-12) questionnaire at six months. The specific PISQ-12 score was based upon Question 3.5, Do you feel pain during sexual intercourse? The subjects' response was counted as having de novo dyspareunia if the response was sometimes usually or always.

Time frame: 6 months

Population: The 12 sexually active subjects without dyspareunia at baseline.

ArmMeasureValue (NUMBER)
Restorelle Direct FixRates of de Novo Dyspareunia0 percentage of subjects
Secondary

Rates of de Novo Dyspareunia

Percentage of de novo dyspareunia measured via validated Participant Sexual Function Questionnaire-12 (PISQ-12) questionnaire at 12 months. The specific PISQ-12 score was based upon Question 3.5, Do you feel pain during sexual intercourse? The subjects' response was counted as having de novo dyspareunia if the response was sometimes usually or always.

Time frame: 12 months

Population: The 11 sexually active subjects without dyspareunia at baseline. At the 12 month follow-up visit, only 11 subjects were sexually active and thus only 11 subjects completed Question 3.5 on the PISQ-12 questionnaire. Therefore, the number of participants analyzed for this outcome was 11 at the 12 month follow-up visit.

ArmMeasureValue (NUMBER)
Restorelle Direct FixRates of de Novo Dyspareunia9.1 percentage of subjects
Secondary

Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 12 Months

Sexual function in women with pelvic organ prolapse is measured by the PISQ-12 at12 months. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.

Time frame: Baseline and 12 months

Population: The 25 subjects who completed the PISQ-12 at the twelve month follow up visit.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 12 Months12 month12.8 units on a scaleStandard Deviation 6.2
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 12 MonthsBaseline15.7 units on a scaleStandard Deviation 6.2
p-value: 0.034t-test, 2 sided
Secondary

Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 3 Months

Sexual function in women with pelvic organ prolapse is measured by the PISQ-12 at 3 months. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.

Time frame: Baseline and 3 months

Population: The 25 subjects who completed the PISQ-12 at the three month follow up visit.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 3 Months3 month12.2 units on a scaleStandard Deviation 5.2
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 3 MonthsBaseline15.7 units on a scaleStandard Deviation 6.2
p-value: 0.001t-test, 2 sided
Secondary

Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 Months

Sexual function in women with pelvic organ prolapse is measured by the PISQ-12 at 6 months. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.

Time frame: Baseline and 6 months

Population: The 26 subjects who completed the PISQ-12 at the six month follow up visit.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 Months6 months12.8 units on a scaleStandard Deviation 5.4
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 MonthsBaseline15.7 units on a scaleStandard Deviation 6.2
p-value: 0.004t-test, 2 sided
Secondary

Sexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 Weeks

Sexual function in women with pelvic organ prolapse is measured by the PISQ-12 at 6 weeks. The scores range from 0-48 with lower scores indicating better sexual function. Scores are calculated by totalling the scores for each question with (4) always, (3) usually, (2) sometimes, (1) seldom, and (0) never. Reverse scoring is used for items 1, 2, 3 and 4. The short form questionnaire can be used with up to two missing responses. To handle missing values, the sum is calculated by multiplying the number of items by the mean of the answered items.

Time frame: Baseline and 6 weeks

Population: The 28 subjects who completed the PISQ-12 at the six week follow up visit.

ArmMeasureGroupValue (MEAN)Dispersion
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 WeeksBaseline15.7 units on a scaleStandard Deviation 6.2
Restorelle Direct FixSexual Function After Vaginal Reconstruction With Restorelle Direct Fix Measured by Participant Sexual Function Questionnaire-12 (PISQ-12) at 6 Weeks6 weeks14.7 units on a scaleStandard Deviation 4.9
p-value: 0.202t-test, 2 sided

Source: ClinicalTrials.gov ยท Data processed: Feb 4, 2026